Back to Top Skip to main content
Need larger text?

2016 Meetings

February 2016

Class Review  Designated Newly Approved Drugs FDA Innovator Drugs 
  • Oral Contraceptives
  • Antifungal Agents - Topical Laquers
  • Opthalmic Anti-Inflammatory/ Immunomodulatory Agents - Ophthalmic Immunomodulatory Agents
 Tivorbex, Pazeo, Afrezza, Striverdi Respimat

Rexulti, Entresto -Solicitation cancelled
 Adynovate, Alecensa, Coagadex, Cotellic, Durlaza, Dyanavel XR, Genvoya, Narcan nasal, Ninlaro, Seebri Neohaler, Strensiq, Tagrisso, Tresiba, Uptravi, Utibron Neohaler, Varubi, Veltassa, Vivlodex

May 11-12, 2016

Class Review  Designated Newly Approved Drugs FDA Innovator Drugs 
  • Oral Contraceptives - Emergency Contraceptives
  • Anticonvulsants
  • Antipsychotic Agents - Atypical
 Entresto, Viberzi

Zecuity - Solicitation Cancelled 		Adzenys XR-ODT, Belbuca, Enstilar, Idelvion, Kovaltry, Odefsey, Quillichew ER, Taltz, Vraylar, Xeljanx XR, Xuriden, Zepatier

August 10-11, 2016

Class Review  Designated Newly Approved Drugs FDA Innovator Drugs 
  • Acne Agents - Topical and Roseacea Agents
  • Migraine Agents - Triptans
  • Alcohol Deterrents - Narcotic Antagonists
 N/A Afstyla, Briviact, Cabometyx, Aczone, Descovy, Epclusa, Ferriprox, Jentadueto XR, Nuplazid, Ocaliva, Orfadin, Sernivo, Onzetra Xsail, Zembrance SymTouch, Tolak, Ultravate, Venclexta, Xtampza ER

November 16-17, 2016

Class Review  Designated Newly Approved Drugs FDA Innovator Drugs 
  • Anticoagulants - Oral Anticoagulants
  • Antilipidemics-1 - PCSK9s
 Spiriva Respimat
 Bevespi Aeroshere, Byvalson, Emend, Gonitro, Invokamet XR, Otovel, Qbrelis, Relistor, Taytulla, Vonvendi, Xiidra, Yosprala, Zinbryta, Zurampic

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing:: Download a PDF Reader or learn more about PDFs.
You are leaving Health.mil

The appearance of hyperlinks does not constitute endorsement by the Defense Health Agency of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.

 You are leaving Health.mil View the external links disclaimer. OK Cancel